Search
Search Results
##search.searchResults.foundPlural##
-
CAR-T CELL THERAPY IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA CAR-T CELL and B-ALL
4571PDF: 3752HTML: 373 -
CAR-T CELL THERAPY IN LARGE B CELL LYMPHOMA CAR-T; Large B Cell Lymphoma; Salvage Therapy,
3865PDF: 1538HTML: 347 -
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
4619PDF: 1785HTML: 1223 -
AUTOLOGOUS STEM CELL TRANSPLANTATION FOR AGGRESSIVE LYMPHOMAS
2691PDF: 900HTML: 2132 -
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3719PDF: 2600HTML: 1625 -
TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML
2287PDF: 1838HTML: 838 -
-
THE ROLE OF AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION IN FOLLICULAR LYMPHOMA IN THE NEW DRUGS ERA.
4158PDF: 1197HTML: 2107Fig.1: 228Fig. 2: 123Table 1: 224Table2: 243Table 3: 223 -
CAR-T CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA CAR-T and CLL
3869PDF: 1687HTML: 89 -
ANTIFUNGAL THERAPY IN HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
4862PDF: 1603HTML: 2265Untitled: 252Untitled: 266Untitled: 286Untitled: 236Untitled: 253 -
HHVs AND LYMPHOPROLIFERATIVE DISORDERS
1472PDF: 855HTML: 3136 -
PATHOBIOLOGY OF HODGKIN LYMPHOMA
3354PDF: 1511HTML: 5966Fig1-Ag-Pil: 260Ag-Pil Fig.2: 259 -
POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS: ROLE OF VIRAL INFECTION, GENETIC LESIONS AND ANTIGEN STIMULATION IN THE PATHOGENESIS OF THE DISEASE
1417PDF: 486HTML: 18624Figure 1: 186Figure 2: 165Figure 3: 183Figure 4: 219Figure 5: 195 -
OUTCOME OF PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA RELAPSING AFTER AUTOLOGOUS TRANSPLANT BEFORE AVAILABILITY OF CAR-T CELL TREATMENT Outcome of DLBCL patients relapsing after ASCT
1463HTML: 397PDF: 997Suppl. Files: 487 -
CROCIN PROMOTES APOPTOSIS IN HUMAN EBV-TRANSFORMED B-LYMPHOCYTE VIA INTRINSIC PATHWAY CROCIN PROMOTES APOPTOSIS IN EBV-TRANSFORMED LCL
1377PDF: 548HTML: 295 -
CURRENT KNOWLEDGE ON HIV-ASSOCIATED PLASMABLASTIC LYMPHOMA
2692PDF: 1674HTML: 2451Table1: 212 -
ROLE OF HEMATOPOIETIC STEM CELL TRANSPLANTATION
2119PDF: 845HTML: 1102 -
INFECTIONS AND FOLLICULAR LYMPHOMA: IS THERE A LINK?
3339PDF: 1064HTML: 2403 -
TDT Positive High-Grade Lymphoma with Myc, BCL2 And BCL6 Rearrangements: a Review of Diagnosis and Treatment TDT POSITIVE HIGH-GRADE LYMPHOMA WITH MYC, BCL2 AND BCL6 REARRANGEMENTS.
2002PDF: 821HTML: 580 -
-
IMMUNOGLOBULIN GENE REPERTOIRE IN CHRONIC LYMPHOCYTIC LEUKEMIA: INSIGHT INTO ANTIGEN SELECTION AND MICROENVIRONMENTAL INTERACTIONS
3193PDF: 925HTML: 7303Kost Fig1: 211Kost Fig 2: 198Kost Fig3: 204Kost Fig 4: 216Kost Fig5: 215Kost fig 6: 202 -
MODERN IMMUNOTHERAPY OF ADULT B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA WITH MONOCLONAL ANTIBODIES AND CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS
2377PDF: 1363HTML: 17204Bassan Fig.1: 161Bassan Fig.2: 264Bassan Fig.4: 154Fig.3: 226 -
SYSTEMIC MASTOCYTOSIS: MULTIDISCIPLINARY APPROACH Systemic Mastocytosis
1658PDF: 1104HTML: 478 -
NASAL NK/T- CELL LYMPHOMA. COMPARATIVE ANALYSIS OF A MEXICAN POPULATION
1836PDF: 1020HTML: 1878Tables: 197 -
Hsa-miR-5581-3p and hsa-miR-542-3p target the F8 gene in hemophilia A without F8 mutations F8 gene is regulated by miRNAs
1180PDF: 539HTML: 385 -
CLINICAL ASPECTS AND THERAPY OF SPORADIC BURKITT LYMPHOMA
1355PDF: 615HTML: 4149 -
CENTRAL NERVOUS SYSTEM INVOLVEMENT IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA: DIAGNOSTIC TOOLS, PROPHYLAXIS AND THERAPY
4321PDF: 1984HTML: 5517Table 1: 234 -
Follicular Lymphoma: A Clinicopathological Analysis from a Tertiary care Institute in Southern India
3525PDF: 821HTML: 3022Figure 1a and 1b: 171Figure 2: 179Figure 3: 198Figure 4: 178Figure 5: 183Tables 1-5: 167 -
Skin Manifestations associated with Mantle cell Lymphoma: a case report
1624PDF: 801HTML: 2184Untitled: 249Untitled: 221Untitled: 210Untitled: 229Untitled: 225 -
NOVEL DRUGS IN FOLLICULAR LYMPHOMA
5785PDF: 1566HTML: 1663Untitled: 258 -
REAL-WORLD OUTCOME IN THE PRE-CAR-T ERA OF MYELOMA PATIENTS QUALIFYING FOR CAR-T CELL THERAPY Real-world Assessment of Myeloma Patients as Candidates for CAR-T Therapy
1668PDF: 682HTML: 1432 -
The labyrinth of pyrexia of unknown origin: A case of intravascular B cell lymphoma
1855PDF: 714HTML: 2428Untitled: 172Figure 1 a: 184Figure 1 b: 187Fig 1 c: 172Figure 1 d: 218 -
Aberrant acquisition of T-cell associated markers in plasma cell neoplasms: An aggressive disease with extramedullary involvement and very short survival Aberrant T markers on malignant plasma cells
2075PDF: 446HTML: 230







